Skip to main content
. 2018 Nov 9;8:16633. doi: 10.1038/s41598-018-34747-3

Figure 3.

Figure 3

FGF-2, but not ASC-CMed, inhibits the protein expression of mesenchymal markers. (A) SM22α, and (B) αSMA, by immunoblotting of NHCF-V after stimulation with TGFβ1 or co-stimulation with TGF-β1 and FGF-2, both in FBM and ASC-CMed, for five days. Data were analyzed by One-way ANOVA with Sidak’s multiple comparison test for the groups FBM/TGF-β1 vs. FBM/TGF-β1/FGF-2 and FBM/TGF-β1 vs. ASC-CMed/TGF-β1; p-values for the Sidak’s multiple comparison test are shown in the figure. Values represent mean ± SEM of 3 independent experiments.